SPHK2 Antikörper (Long Isoform, N-Term)
Kurzübersicht für SPHK2 Antikörper (Long Isoform, N-Term) (ABIN4620350)
Target
Alle SPHK2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- Long Isoform, N-Term
-
Spezifität
- This antibody detetcts Sphingosine Kinase 2 (Long Form).
-
Aufreinigung
- Ligand affinity chromatography
-
Immunogen
- Synthetic peptide derived from the N-terminal extension of the Sphingosine Kinase 2-L protein
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
Western blot: (1-5 μg/mL). Positive control: Jurkat lysate. ELISA.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Buffer
- Phosphate buffered saline with 0.08 % sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Upon arrival, aliquot and freeze at -20 °C to -70 °C.
-
-
- SPHK2 (Sphingosine Kinase 2 (SPHK2))
-
Andere Bezeichnung
- Sphingosine Kinase 2 / SPK2
-
Hintergrund
- The long form of sphingosine kinase 2 (Sphk2-L) is a species-specific isoform of the Sphk2 enzyme expressed in human but not in mouse. It is an N-terminal extended form of Sphk2, extended by 36 amino acids. It functions as expected, catalyzing the formation of sphingosine 1-phosphate from sphingosine, however it appears to have a decreased ability to inhibit DNA synthesis as compared to Sphk2-S (short form of Sphk2). Under normal cellular conditions, Sphk2-L does not appear to inhibit DNA synthesis, but under serum deprivation, SphK2-L translocates to the nucleus and accumlates. This accumlation may be involved in the cessation of cell proliferation or apoptosis depending on the cell type.Synonyms: SK2, SPHK2
-
Gen-ID
- 56848
-
NCBI Accession
- NP_064511
-
UniProt
- Q9NRA0
-
Pathways
- VEGF Signaling
Target
-